Cargando…
Antithrombotic Therapies in COVID-19 Disease: a Systematic Review
BACKGROUND: Infection with coronavirus SARS-CoV-2, causing COVID-19 disease, leads to inflammation and a prothrombotic state. OBJECTIVE: This rapid systematic review aims to synthesize evidence on thromboembolism incidence and outcomes with antithrombotic therapies in COVID-19. DATA SOURCES: We sear...
Autores principales: | Maldonado, Edward, Tao, Derrick, Mackey, Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299557/ https://www.ncbi.nlm.nih.gov/pubmed/32556875 http://dx.doi.org/10.1007/s11606-020-05906-y |
Ejemplares similares
-
Antithrombotic therapy in COVID-19
por: Saeed, Sahrai, et al.
Publicado: (2021) -
Antithrombotic therapy and survival in patients with malignant disease
por: Kakkar, A K, et al.
Publicado: (2010) -
Antithrombotic therapy in TAVI
por: Vavuranakis, Manolis, et al.
Publicado: (2018) -
Is it time to move to systematic antithrombotic prophylaxis or therapy for all patients with COVID-19 disease?
por: Njonnou, Sylvain Raoul Simeni, et al.
Publicado: (2021) -
Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis
por: Willems, Loes H., et al.
Publicado: (2022)